Fate Therapeutics Inc
NASDAQ: FATE · HEALTHCARE · BIOTECHNOLOGY
Updated 2026-07-29
Fate Therapeutics Inc (FATE) Insider transactions
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | XU, YUAN | Director | Buy | 87,900 | — | — |
| 2026-06-12 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 87,900 | — | — |
| 2026-06-12 | RASTETTER, WILLIAM H | Director | Buy | 87,900 | — | — |
| 2026-06-12 | LEE, MICHAEL STEWART | Director | Buy | 87,900 | — | — |
| 2026-06-12 | JOOSS, KARIN | Director | Buy | 87,900 | — | — |
| 2026-06-12 | HAMILL, LAURA | Director | Buy | 175,800 | — | — |
| 2026-06-12 | EPSTEIN, ROBERT S | Director | Buy | 87,900 | — | — |
| 2026-06-12 | AGARWAL, SHEFALI | Director | Buy | 87,900 | — | — |
| 2026-06-12 | ABERNETHY, MATT | Director | Buy | 87,900 | — | — |
| 2026-05-20 | VALAMEHR, BAHRAM | Director, President and CEO | Sale | 28,946 | $1.88 | $54482.16 |
| 2026-05-20 | TAHL, CINDY | See Remarks | Sale | 25,590 | $1.88 | $48083.61 |
| 2026-05-06 | TAHL, CINDY | See Remarks | Sale | 122,220 | — | — |
| 2026-05-06 | TAHL, CINDY | See Remarks | Sale | 44,444 | — | — |
| 2026-05-06 | TAHL, CINDY | See Remarks | Buy | 122,220 | $1.32 | $161330.40 |
| 2026-05-06 | TAHL, CINDY | See Remarks | Buy | 44,444 | $1.05 | $46666.20 |
| 2026-05-05 | RASTETTER, WILLIAM H | Director | Buy | 25,000 | — | — |
| 2026-05-05 | RASTETTER, WILLIAM H | Director | Buy | 25,000 | $1.69 | $42250.00 |
| 2026-05-05 | EPSTEIN, ROBERT S | Director | Buy | 25,000 | — | — |
| 2026-05-05 | EPSTEIN, ROBERT S | Director | Buy | 25,000 | $1.69 | $42250.00 |
| 2026-04-20 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 3,691,324 | — | — |
| 2026-04-20 | REDMILE, GROUP, LLC | Director, 10% Owner | Sale | 8,977,624 | — | — |
| 2026-04-20 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 162,013 | — | — |
| 2026-04-20 | REDMILE, GROUP, LLC | Director, 10% Owner | Sale | 266,280 | — | — |
| 2026-01-15 | VALAMEHR, BAHRAM | Director, President and CEO | Buy | 1,300,000 | — | — |
| 2026-01-15 | VALAMEHR, BAHRAM | Director, President and CEO | Buy | 335,000 | — | — |
| 2026-01-15 | TAHL, CINDY | See Remarks | Buy | 400,000 | — | — |
| 2026-01-15 | TAHL, CINDY | See Remarks | Buy | 100,000 | — | — |
| 2026-01-15 | ADAWI, KAMAL | Chief Financial Officer | Buy | 75,000 | — | — |
| 2026-01-15 | ADAWI, KAMAL | Chief Financial Officer | Buy | 25,000 | — | — |
| 2026-01-09 | VALAMEHR, BAHRAM | Director, President and CEO | Sale | 5,190 | $1.07 | $5557.45 |
| 2026-01-09 | TAHL, CINDY | See Remarks | Sale | 10,589 | $1.06 | $11275.17 |
| 2025-10-20 | ADAWI, KAMAL | Chief Financial Officer | Buy | 375,000 | — | — |
| 2025-10-20 | ADAWI, KAMAL | Chief Financial Officer | Buy | 75,000 | — | — |
| 2025-08-04 | VALAMEHR, BAHRAM | Director, President and CEO | Sale | 14,466 | $1.06 | $15396.16 |
| 2025-08-04 | TAHL, CINDY | See Remarks | Sale | 9,037 | $1.06 | $9572.89 |
| 2025-05-29 | XU, YUAN | Director | Buy | 55,000 | — | — |
| 2025-05-29 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 55,000 | — | — |
| 2025-05-29 | RASTETTER, WILLIAM H | Director | Buy | 55,000 | — | — |
| 2025-05-29 | MOZAFFARIAN, NEELUFAR | Director | Buy | 55,000 | — | — |
| 2025-05-29 | MENDLEIN, JOHN | Director | Buy | 55,000 | — | — |
| 2025-05-29 | LEE, MICHAEL STEWART | Director | Buy | 55,000 | — | — |
| 2025-05-29 | JOOSS, KARIN | Director | Buy | 55,000 | — | — |
| 2025-05-29 | EPSTEIN, ROBERT S | Director | Buy | 55,000 | — | — |
| 2025-05-29 | AGARWAL, SHEFALI | Director | Buy | 55,000 | — | — |
| 2025-05-29 | ABERNETHY, MATT | Director | Buy | 110,000 | — | — |
| 2025-01-16 | VALAMEHR, BAHRAM | Director, President and CEO | Buy | 1,300,000 | — | — |
| 2025-01-15 | TAHL, CINDY | See Remarks | Buy | 275,000 | — | — |
| 2025-01-15 | TAHL, CINDY | See Remarks | Buy | 70,000 | — | — |
| 2025-01-15 | BRESSI, JEROME CHARLES | See Remarks | Buy | 250,000 | — | — |
| 2025-01-15 | BRESSI, JEROME CHARLES | See Remarks | Buy | 65,000 | — | — |
| 2025-01-10 | VALAMEHR, BAHRAM | Director, President and CEO | Sale | 8,705 | $1.54 | $13405.70 |
| 2025-01-10 | TAHL, CINDY | See Remarks | Sale | 5,654 | $1.55 | $8763.70 |
| 2025-01-10 | BRESSI, JEROME CHARLES | See Remarks | Sale | 5,980 | $1.55 | $9269.00 |
| 2024-12-20 | REDMILE, GROUP, LLC | Director, 10% Owner | Sale | 1,084,936 | $1.68 | $1.82M |
| 2024-12-20 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 397,964 | $1.68 | $668579.52 |
| 2024-12-20 | REDMILE, GROUP, LLC | Director, 10% Owner | Sale | 341,633 | $1.68 | $573943.44 |
| 2024-12-20 | REDMILE, GROUP, LLC | Director, 10% Owner | Sale | 116,261 | $8.40 | $976592.40 |
| 2024-12-20 | REDMILE, GROUP, LLC | Director, 10% Owner | Sale | 56,331 | $1.68 | $94636.08 |
| 2024-12-12 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 30,110 | — | — |
| 2024-12-12 | REDMILE, GROUP, LLC | Director, 10% Owner | Sale | 6,022 | — | — |
| 2024-08-06 | XU, YUAN | Director | Sale | 633 | $4.23 | $2677.59 |
| 2024-07-29 | VALAMEHR, BAHRAM | Chief R&D Officer | Buy | 200,000 | — | — |
| 2024-07-29 | TAHL, CINDY | General Counsel and Secretary | Buy | 200,000 | — | — |
| 2024-07-29 | MOZAFFARIAN, NEELUFAR | Director | Buy | 80,000 | — | — |
| 2024-06-07 | XU, YUAN | Director | Buy | 40,000 | — | — |
| 2024-06-07 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 40,000 | — | — |
| 2024-06-07 | RASTETTER, WILLIAM H | Director | Buy | 40,000 | — | — |
| 2024-06-07 | MENDLEIN, JOHN | Director | Buy | 40,000 | — | — |
| 2024-06-07 | LEE, MICHAEL STEWART | Director | Buy | 40,000 | — | — |
| 2024-06-07 | JOOSS, KARIN | Director | Buy | 40,000 | — | — |
| 2024-06-07 | EPSTEIN, ROBERT S | Director | Buy | 40,000 | — | — |
| 2024-06-07 | COUGHLIN, TIMOTHY | Director | Buy | 40,000 | — | — |
| 2024-06-07 | AGARWAL, SHEFALI | Director | Buy | 40,000 | — | — |
| 2024-03-21 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 3,636,364 | $5.50 | $20.00M |
| 2024-03-04 | DULAC, EDWARD J III | Chief Financial Officer | Sale | 2,447 | $7.77 | $19013.19 |
| 2024-02-01 | WOLCHKO, J SCOTT | Director, President and CEO | Buy | 500,000 | — | — |
| 2024-02-01 | VALAMEHR, BAHRAM | Chief R&D Officer | Buy | 450,000 | — | — |
| 2024-02-01 | TAHL, CINDY | General Counsel and Secretary | Buy | 425,000 | — | — |
| 2024-02-01 | DULAC, EDWARD J III | Chief Financial Officer | Buy | 425,000 | — | — |
| 2024-01-29 | DULAC, EDWARD J III | Chief Financial Officer | Sale | 1,849 | $5.00 | $9245.00 |
| 2024-01-09 | WOLCHKO, J SCOTT | Director, President and CEO | Sale | 14,391 | $4.37 | $62888.67 |
| 2024-01-09 | VALAMEHR, BAHRAM | Chief R&D Officer | Sale | 11,271 | $4.38 | $49366.98 |
| 2024-01-09 | TAHL, CINDY | General Counsel and Secretary | Sale | 10,874 | $4.37 | $47519.38 |
| 2024-01-09 | DULAC, EDWARD J III | Chief Financial Officer | Sale | 7,028 | $4.37 | $30712.36 |
| 2024-01-02 | DULAC, EDWARD J III | Chief Financial Officer | Sale | 5,182 | $3.66 | $18966.12 |
| 2023-12-26 | REDMILE, GROUP, LLC | Director, 10% Owner | Sale | 1,655,370 | $3.72 | $6.16M |
| 2023-12-26 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 44,630 | $3.72 | $166023.60 |
| 2023-12-18 | DULAC, EDWARD J III | Chief Financial Officer | Sale | 1,585 | $3.50 | $5547.50 |
| 2023-11-09 | TAHL, CINDY | General Counsel and Secretary | Sale | 24,363 | $2.40 | $58471.20 |
| 2023-08-18 | DULAC, EDWARD J III | Chief Financial Officer | Sale | 4,718 | $2.80 | $13210.40 |
| 2023-08-04 | XU, YUAN | Director | Sale | 632 | $3.71 | $2344.72 |
| 2023-07-05 | POWL, BRIAN T. | Chief Commercial Officer | Sale | 3,854 | $4.87 | $18768.98 |
| 2023-07-05 | DULAC, EDWARD J III | Chief Financial Officer | Sale | 5,182 | $4.83 | $25029.06 |
| 2023-06-14 | XU, YUAN | Director | Sale | 3,460 | $5.58 | $19306.80 |
| 2023-06-06 | XU, YUAN | Director | Buy | 40,000 | — | — |
| 2023-06-06 | REDMILE, GROUP, LLC | Director, 10% Owner | Buy | 40,000 | — | — |
| 2023-06-06 | RASTETTER, WILLIAM H | Director | Buy | 40,000 | — | — |
| 2023-06-06 | MENDLEIN, JOHN | Director | Buy | 40,000 | — | — |
| 2023-06-06 | LEE, MICHAEL STEWART | Director | Buy | 40,000 | — | — |
| 2023-06-06 | JOOSS, KARIN | Director | Buy | 40,000 | — | — |
Frequently asked questions
Are FATE insiders buying or selling?
Over the transactions on record, FATE insiders have been net buyers, with about $10.18M in stock sold across 34 sales, against 7 open-market purchases.
Does insider selling at FATE mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which FATE insiders are selling the most?
Recent selling is concentrated in a few names. REDMILE, GROUP, LLC accounts for the largest share on record, with about $9.63M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.